Trending
- NICE Recommends T-DXd for HER2-Low Metastatic Breast Cancer
- SOHO 2026: Disparities, Efficacy, and Long-Term Safety in B-Cell Lymphoma
- NCCN Guidelines Strengthen MRD Testing Recommendations in Multiple Myeloma
- Mechanisms and disease relevance of DNA break repair pathway choice
- Relacorilant Combo Receives Positive CHMP Opinion in Ovarian Cancer
- Scientists discover cells that cheat death and rebuild damaged tissue
- Subcutaneous Amivantamab Combo is a “Clear” New Standard in EGFR+ NSCLC
- Menopausal hormone therapy and primary liver cancer: long-term follow-up of the women’s health initiative randomized trials
Friday, September 18